Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
AKTIENPREIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership71,906 shares
Latest Disclosed Value $ 584,596
Alps Advisors Inc reports 0.64% increase in ownership of KUR / Kura Oncology, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 71,906 shares of Kura Oncology, Inc. (DE:KUR) valued at $478,175 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 71,447 shares of Kura Oncology, Inc.. This represents a change in shares of 0.64% during the quarter. The current value of the position is $543,609 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F KURA ONCOLOGY COM 50127T109 71,906 459 0.64 585 -21.29 0.0025
2026-02-12 2025-12-31 13F KURA ONCOLOGY COM 50127T109 71,447 32,465 83.28 742 115.70 0.0043
2025-11-05 2025-09-30 13F KURA ONCOLOGY COM 50127T109 38,982 -7,678 -16.46 345 27.88 0.0019
2025-08-11 2025-06-30 13F KURA ONCOLOGY COM 50127T109 46,660 46,660 269 0.0016
2025-02-13 2024-12-31 13F KURA ONCOLOGY COM 50127T109 0 -58,695 -100.00 0 -100.00
2024-11-12 2024-09-30 13F KURA ONCOLOGY COM 50127T109 58,695 -708 -1.19 1,147 -6.30 0.0077
2024-08-13 2024-06-30 13F KURA ONCOLOGY COM 50127T109 59,403 5,703 10.62 1,223 6.81 0.0084
2024-05-14 2024-03-31 13F KURA ONCOLOGY COM 50127T109 53,700 3,221 6.38 1,145 57.93 0.0081
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM 50127T109 50,479 -4,270 -7.80 726 45.29 0.0057
2023-11-14 2023-09-30 13F KURA ONCOLOGY COM 50127T109 54,749 4,441 8.83 499 -6.20 0.0041
2023-08-14 2023-06-30 13F KURA ONCOLOGY COM 50127T109 50,308 5,215 11.56 532 -3.45 0.0046
2023-05-10 2023-03-31 13F KURA ONCOLOGY COM 50127T109 45,093 -1,180 -2.55 551 -4.01 0.0049
2023-02-14 2022-12-31 13F KURA ONCOLOGY COM 50127T109 46,273 9,806 26.89 574 15.26 0.0051
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM 50127T109 36,467 -3,058 -7.74 498 -31.22 0.0047
2022-08-15 2022-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 39,525 39,525 724 0.0070
2022-08-11 2022-06-30 13F KURA ONCOLOGY COM 50127T109 39,525 39,525 724 0.0069
2021-02-03 2020-12-31 13F KURA ONCOLOGY COM 50127T109 0 -71,775 -100.00 0 -100.00
2020-11-05 2020-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 71,775 -2,612 -3.51 2,199 81.29 0.0324
2020-11-04 2020-09-30 13F KURA ONCOLOGY COM 50127T109 71,775 -2,612 2,199 28,182.8195
2020-08-05 2020-06-30 13F KURA ONCOLOGY COM 50127T109 74,387 -8,003 -9.71 1,213 47.93 0.0163
2020-05-06 2020-03-31 13F KURA ONCOLOGY COM 50127T109 82,390 -9,601 -10.44 820 -35.18 0.0127
2020-02-07 2019-12-31 13F KURA ONCOLOGY COM 50127T109 91,991 1,879 2.09 1,265 -7.46 0.0099
2019-11-04 2019-09-30 13F KURA ONCOLOGY IN COMMON STOCK 50127T109 90,112 10,184 12.74 1,367 -13.15 0.0106
2019-08-07 2019-06-30 13F KURA ONCOLOGY IN COMMON STOCK 50127T109 79,928 -11,945 -13.00 1,574 3.28 0.0117
2019-05-01 2019-03-31 13F KURA ONCOLOGY IN COMMON STOCK 50127T109 91,873 3,974 4.52 1,524 23.50 0.0108
2019-02-04 2018-12-31 13F KURA ONCOLOGY IN COMMON STOCK 50127T109 87,899 20,698 30.80 1,234 4.93 0.0096
2018-10-25 2018-09-30 13F KURA ONCOLOGY IN COMMON STOCK 50127T109 67,201 18,801 38.85 1,176 33.48 0.0077
2018-08-02 2018-06-30 13F/A-2 Kura Oncology COMMON STOCK 50127T109 48,400 7,874 19.43 881 15.92 0.0057
2018-07-31 2018-06-30 13F/A-1 Kura Oncology COMMON STOCK 50127T109 33,483 -14,917 512 0.0033
2018-07-25 2018-06-30 13F Kura Oncology COMMON STOCK 50127T109 33,483 -7,043 512
2018-05-01 2018-03-31 13F Kura Oncology COMMON STOCK 50127T109 40,526 7,043 21.03 760 48.44 0.0060
2018-02-20 2017-12-31 13F/A-1 Kura Oncology COMMON STOCK 50127T109 33,483 33,483 512 0.0035
2018-02-05 2017-12-31 13F Kura Oncology COMMON STOCK 50127T109 33,483 512
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.